Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies.

@article{Halabi2006ClinicalOB,
  title={Clinical outcomes by age in men with hormone refractory prostate cancer: a pooled analysis of 8 Cancer and Leukemia Group B (CALGB) studies.},
  author={Susan Halabi and Nicholas John Vogelzang and San-san Ou and William Kevin Kelly and Eric Jay Small},
  journal={The Journal of urology},
  year={2006},
  volume={176 1},
  pages={81-6}
}
PURPOSE We determined if age is a prognostic factor of clinical outcomes, specifically overall survival, disease-free survival and progression-free survival in men with hormone refractory prostate cancer. MATERIALS AND METHODS Data from 8 multi-institutional trials performed by Cancer and Leukemia Group B were combined. Eligible patients had progressive… CONTINUE READING